tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
PHAT
Phathom Pharmaceuticals
RESEARCH TOOLSreports
Want to see PHAT full AI Analyst Report?

Phathom Pharmaceuticals (PHAT) Stock News & Sentiment

589 Followers
Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up
Premium
Company Announcements
Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up
1M ago
PHAT
Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating
Premium
Ratings
Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating
2M ago
PHAT
Phathom Pharmaceuticals Announces $130 Million Public Offering
Premium
Company Announcements
Phathom Pharmaceuticals Announces $130 Million Public Offering
3M ago
8K
PHAT
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
4M ago
LXEO
PHAT
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
Premium
Company Announcements
Phathom Pharmaceuticals Begins Phase 2 EoE Trial
6M ago
8K
PHAT
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
Premium
Company Announcements
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges
6M ago
PHAT
Phathom Pharmaceuticals Reports Strong Q3 2025 Growth
Premium
Company Announcements
Phathom Pharmaceuticals Reports Strong Q3 2025 Growth
6M ago
PHAT
More PHAT News >

PHAT News on the Web

Analysts Have Conflicting Sentiments on These Healthcare Companies: Allogene Therapeutics (ALLO), Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)
TipRanks News
Neutral
Phathom Pharmaceuticals (PHAT) was upgraded to a Buy Rating at Barclays
TipRanks News
Bullish
Phathom Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
TipRanks News
Neutral
Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study
Zacks
Neutral
ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy
Zacks
Bearish
Phathom Pharmaceuticals management to meet with Cantor
TipRanks News
Bullish
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
Zacks
Bullish
Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli
Zacks
Bearish

News Score - Last 7 Days

Neutral
PHAT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHAT’s Media Buzz Sentiment?
1 articles about PHAT were published this week. In an average week, 1.5 articles are published.
    What is PHAT’s weekly average amount of articles?
    In an average week, 1.5 articles about PHAT are published.
      What is PHAT’s News Sentiment?
      50% of articles about PHAT were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        ALLOAllogene Therapeutics
        TXTMProText Mobility
        HVOOpen Orphan Plc
        RVMDRevolution Medicines
        OCCOrthocell Ltd
        Showing the stocks with the most bullish news sentiment over the past week